Effects of ranibizumab and zoledronic acid on endometriosis in a rat model

Autor: Ertan Adali, Umit Inceboz, Mine Islimye Taskin, Altug Yavasoglu, Huseyin Aktug, Fatih Oltulu, Eda Üreyen Özdemir

Publikováno v: Archives of Gynecology and Obstetrics. 306:1399-1405

Purpose To investigate the histological efficacy of ranibizumab and zoledronic acid in an experimentally induced endometriosis model as compared with danazol, buserelin acetate and dienogest. Methods Endometrial implants were introduced in 52 female

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::454cc8fb0fb547337b93f3f62cb6385b
https://doi.org/10.1007/s00404-021-06393-0

Protocol for the Cultural Translation and Adaptation of the World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project Endometriosis Participant Questionnaire (EPHect)

Autor: Cise Mis, Gokcen Kofali, Bethan Swift, Pinar Yalcin Bahat, Gamze Senocak, Bahar Taneri, Lone Hummelshoj, Stacey A. Missmer, Christian M. Becker, Krina T. Zondervan, Bahar Yuksel Ozgor, Engin Oral, Umit Inceboz, Mevhibe B. Hocaoglu, Nilufer Rahmioglu

Publikováno v: Frontiers in Global Women's Health
Frontiers in Global Women's Health, Vol 2 (2021)
Frontiers in Global Women's Health, 2:644609. Frontiers Research Foundation

Endometriosis affects 10% of women worldwide and is one of the most common causes of chronic pelvic pain and infertility. However, causal mechanisms of this disease remain unknown due to its heterogeneous presentation. In order to successfully study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ef4ef73fd8a902b68156cc97a58944c
https://pubmed.ncbi.nlm.nih.gov/34816197

How can we manage patients over forty with endometriosis?

Autor: Umit Inceboz, Engin Oral

Publikováno v: Minerva medica. 111(1)

Peri/postmenopausal endometriosis is not as rare as once we thought. Accumulated data revealed that around 1/3-1/4 of women with surgically-diagnosed endometriosis after the age of 40. The uneasiness of the issue of malignant transformation or malign

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e80d6440b4645ea1e0501819c0760f8
https://pubmed.ncbi.nlm.nih.gov/31828985

Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome

Autor: Mine Islimye Taskin, Adnan Adil Hismiogullari, Erdogan Bulbul, Umit Inceboz, Ertan Adali

Publikováno v: European Journal of Obstetrics & Gynecology and Reproductive Biology. 189:19-23

Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies, affecting 5-8% of reproductive-age women. It is associated with insulin resistance, central obesity, type 2 diabetes mellitus, dyslipidemia, and cardiovascular diseases. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8854804e5dc8288fe7400cb196345d5e
https://doi.org/10.1016/j.ejogrb.2015.03.006

Endometriosis and ovarian reserve

Autor: Engin Oral, Umit Inceboz, Berfu Demir

Publikováno v: Women's health (London, England). 11(5)

Endometriosis is characterized by development of the endometrial tissue outside the uterus like ovary, pelvic peritoneum, pelvic organs, and affects 6-10% of reproductive-aged women. The prevalence of endometrioma is 17-44% of women with endometriosi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66563accd4ed7475587762405b977dfd
https://pubmed.ncbi.nlm.nih.gov/26344663